Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells

Mostrar otras versiones (1)

The splicing factor SF3B1 is the most commonly mutated gene in the myelodysplastic syndrome (MDS), particularly in patients with refractory anemia with ring sideroblasts (RARS). We investigated the functional effects of SF3B1 disruption in myeloid cell lines: SF3B1 knockdown resulted in growth inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Dolatshad, H, Pellagatti, A, Fernandez-Mercado, M, Yip, B H, Malcovati, L, Attwood, M, Przychodzen, B, Sahgal, N, Kanapin, A A, Lockstone, H, Scifo, L, Vandenberghe, P, Papaemmanuil, E, Smith, C W J, Campbell, P J, Ogawa, S, Maciejewski, J P, Cazzola, M, Savage, K I, Boultwood, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430703/
https://www.ncbi.nlm.nih.gov/pubmed/25428262
http://dx.doi.org/10.1038/leu.2014.331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430703/
https://www.ncbi.nlm.nih.gov/pubmed/25428262
http://dx.doi.org/10.1038/leu.2014.331

Ejemplares similares